See All Slides -

Slides

Presentation TCT 2012

TCT-110: First Experience with a Novel Anatomically Adapted Percutaneous Heart Valve for the Tricuspid Position

Presenter: Desiree Pott

October 22, 2012

Presentation TCT 2012

SDF-1: Circumventing the Application of Cell Products in Heart Failure

Presenter: Warren Sherman

October 22, 2012

Presentation TCT 2012

LIMA Intervention – Travails and Innovative Solutions

Presenter: Haresh Mehta

October 22, 2012

Presentation TCT 2012

ISAR-SAFE Update

Presenter: Adnan Kastrati

October 22, 2012

Presentation TCT 2012

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

Presenter: Neil Weissman

October 22, 2012

Presentation TCT 2012

Bifurcation Anatomy, Angulation, and Lesion Complexity: Implications for Procedural Outcomes and Long-term Patency

Presenter: Debabrata Dash

October 22, 2012

Presentation TCT 2012

Case Presentation (with Discussion): Recurrent DES Restenosis

Presenter: Simon Walsh

October 22, 2012

Presentation TCT 2012

The Importance of Frailty Assessments in TAVR Patient Selection: Phenotype Description, Measurement Tools, and Impact on Clinical Outcomes

Presenter: Philip Green

October 22, 2012

Presentation TCT 2012

DES vs. BMS in STEMI: Why Is This Such a Difficult Decision?

Presenter: Giuseppe De Luca

October 22, 2012

Presentation TCT 2012

Step 3: Intellectual Property

Presenter: Casey McGlynn

October 22, 2012

Advertisement

Slides

TCT-110: First Experience with a Novel Anatomically Adapted Percutaneous Heart Valve for the Tricuspid Position

SDF-1: Circumventing the Application of Cell Products in Heart Failure

LIMA Intervention – Travails and Innovative Solutions

ISAR-SAFE Update

Demographics and Echocardiography of Aortic Stenosis in the Modern Era: Insights from the PARTNER Trial

Bifurcation Anatomy, Angulation, and Lesion Complexity: Implications for Procedural Outcomes and Long-term Patency

Case Presentation (with Discussion): Recurrent DES Restenosis

The Importance of Frailty Assessments in TAVR Patient Selection: Phenotype Description, Measurement Tools, and Impact on Clinical Outcomes

DES vs. BMS in STEMI: Why Is This Such a Difficult Decision?

Step 3: Intellectual Property

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content